IRadimed Corporation
IRadimed Corporation (IRMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IRMD · as of Jun 8, 2026
Key Statistics
Explore IRadimed Corporation Data
irmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The IRMD analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $120.00, representing +27.13% upside from the current price of $94.39.
Competitors & Peers
irmd competitorsIRMD
AHCO
AXGN
CRON
CTEV
GDRXStock Performance
Full HistoryAbout IRadimed Corporation
IRadimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and interna…
what is iradimed corporation · irmd stock overview · iradimed corporation company profile · who is iradimed corporation ceo · irmd NASDAQ · iradimed corporation headquarters · iradimed corporation business segments
About Stock Overview & Key Data
IRadimed Corporation (IRMD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 16, 2014. As of the latest trading session, IRMD stock price is $94.39, with a market capitalization of $1.2B. The stock has returned +55.29% over the past 12 months and -2.94% year-to-date.
According to 2 Wall Street analysts, the consensus rating for IRadimed Corporation stock is Buy, with an average 12-month price target of $120.00. In fiscal year 2025, IRadimed Corporation reported revenue of $83.8M and net income of $22.5M. For detailed data — including IRadimed Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IRadimed Corporation (IRMD) stock price is $94.39. The stock is traded on NASDAQ under the ticker symbol IRMD. The 52-week range is $55.11 – $107.90.